Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-28

Clinical Trial Update: A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating sitagliptin added during metformin up-titration in adults with type 2 diabetes; completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)
  • metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-02-28